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The Chromatin Remodeler Mi-2 Is Required
for CD4 Expression and T Cell Development
are capable of differentiating into T cells, B cells, or NK
cells (Shortman and Wu, 1996). Early T lineage-restricted
precursors express neither CD4 nor CD8 coreceptors
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and are designated double-negative (DN) cells. In-frameXiaoqing Qi,1 Piper Keables,1
rearrangement of the T cell receptor  (TCR) locus andUlrich H. Von Andrian,2 and Katia Georgopoulos1,*
cell surface expression of TCR protein within the pre-1Cutaneous Biology Research Center
TCR complex (termed “ selection”) signals cells to pro-Massachusetts General Hospital
liferate and acquire both CD4 and CD8 coreceptors,Harvard Medical School
with CD8 usually being expressed first in most mouseCharlestown, Massachusetts 02129
strains (von Boehmer et al., 1998). The resulting cells2 Center for Blood Research
are termed double-positive (DP) thymocytes. ProductiveDepartment of Pathology
recombination at the TCR locus results in the expres-Harvard Medical School
sion of intermediate levels of the TCR complex onBoston, Massachusetts 02115
the surface of DP cells. Most DP thymocytes (95%) die,
either because their T cell receptors interact poorly with
peptide major histocompatability complexes (MHC) orSummary
because they bind too efficiently to self ligands and
autoimmunity is risked (Robey and Fowlkes, 1994). AChanges in chromatin structure underlie the activation
small number of DP thymocytes expressing TCRs thator silencing of genes during development. The chro-
recognize self MHC-ligand complexes with the appro-matin remodeler Mi-2 is highly expressed in thy-
priate signal intensity are “positively selected” throughmocytes and is presumed to be a transcriptional re-
a multistep process to become mature single-positivepressor because of its presence in the nucleosome
(SP) cells (Guidos, 1996). SP thymocytes maintain ex-remodeling deacetylase (NuRD) complex. Using con-
pression of one coreceptor while the other coreceptorditional inactivation, we show that Mi-2 is required
is silenced. These are referred to as lineage-specifiedat several steps during T cell development: for differ-
CD4 or CD8 mature T cells, which exit the thymus toentiation of  selected immature thymocytes, for de-
circulate to the periphery.velopmental expression of CD4, and for cell divisions
The genetic elements that define the putative controlin mature T cells. We further show that Mi-2 plays a
regions in the CD4 and CD8 genes have been extensivelydirect role in promoting CD4 gene expression. Mi-2
characterized (Kioussis and Ellmeier, 2002). Activationassociates with the CD4 enhancer as well as the E box
of the CD4 locus relies on a 5 proximal enhancer thatbinding protein HEB and the histone acetyltransferase
is active throughout T cell development (Killeen et al.,(HAT) p300, enabling their recruitment to the CD4 en-
1993; Sawada and Littman, 1991; Sawada et al., 1994)hancer and causing histone H3-hyperacetylation to
and possibly a 3 enhancer/LCR that functions coordi-this regulatory region. These findings provide impor-
nately with the 5 enhancer at the DP stage (Adlam andtant insights into the regulation of CD4 expression
Siu, 2003). Expression of CD4 during T cell differentiationduring T cell development and define a role for Mi-2
is restricted to DP and CD4 SP cells by a silencer thatin gene activation.
overrides the activity of the 5 enhancer in DN and CD8
SP cells, thus conferring a lineage-specific expressionIntroduction
pattern (Sawada et al., 1994; Siu et al., 1994). Recent
genetic studies have implied DNA binding and chroma-
The precise regulation of gene expression is fundamen-
tin remodeling factors in the regulation of CD4 and CD8
tal to cell fate decisions and lineage specification during gene expression during T cell differentiation (Kioussis
all developmental processes. Heritable changes in chro- and Ellmeier, 2002). Studies on CD4 regulation have
matin structure are increasingly recognized as critical focused on factors governing its lineage restriction
events in shaping the gene expression pattern specific through silencer activity and have shown a dependence
to each cell lineage. T cell development in the immune on the Runt domain-containing DNA binding factors
system is one of the best-studied paradigms of lineage Runx1 and Runx3 and the SWI/SNF chromatin remodel-
specification. During the process, the coordinated ac- ing complex (Chi et al., 2002; Taniuchi et al., 2002).
quisition of CD4 and CD8 coreceptors in maturing T The 2 MDa nucleosome remodeling histone deacety-
cells follows a complex pattern of gene expression, lase (NuRD) complex (Tong et al., 1998; Xue et al., 1998;
whereby these molecules function both as stage-spe- Zhang et al., 1998) is highly expressed in the thymus and
cific markers and as functional signaling complexes that associates with the Ikaros family of lymphoid-lineage
direct cell fate toward the helper and cytotoxic T cell regulating factors in differentiating and mature T cells,
lineages, respectively. suggesting that this chromatin remodeling complex may
The most immature thymic precursor cells to seed the be important for T cell development (Kim et al., 1999).
thymus from the bone marrow retain multipotency and The NuRD complex is comprised of at least eight poly-
peptides, including Mi-2, a SNF2-like ATP-dependent
chromatin remodeler. Genetic studies in C. elegans and*Correspondence: katia.georgopoulos@cbrc2.mgh.harvard.edu
3 These authors have contributed equally to this work. Drosophila and biochemical purification of vertebrate
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Figure 1. Lckpr-Cre-Induced Deletion of Mi-2 in Developing T Cells
(A) For conditional inactivation strategy, exons 12–21 of Mi-2 were flanked by LoxP sites (black triangles); the Neo marker was flanked by
Frt sites (white triangles). Flp recombinase excises the Neo gene from the targeting construct and generates the Mi-2LoxPF allele. Lckpr-Cre
recombinase induced deletion of the Mi-2 ATPase domain in thymocytes, generating the Mi-2F allele, or if introduced before Flp, the Mi-
2 (Neo) allele.
(B) Southern blot analysis of Mi-2 deletion efficiency. Genomic DNA from tail, thymus, lymph nodes (LN), and LN T cells (LN T) was extracted
from wt (Mi-2/), heterozygous (Lckpr-Cre/Mi-2/LoxPF), or Mi-2-deficient (Lckpr-Cre/Mi-2/LoxPF) mice. EcoRI-digested DNA was probed as
indicated in (A). Digestion fragments from both the  and LoxPF alleles migrated at 8.5 kb; the  allele (Neo) migrated at 5 kb. The 8.5 kb
LoxP fragment was reduced to 3.5 kb after Cre-mediated excision of exons 12–21 of Mi-2 (F). Deletion efficiency was 95% in thymus and
varied from 13%–45% in total LN and 15%–65% in LN T cells.
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Mi-2 with HDACs have implied that Mi-2 is a negative and SP (Figure 1C, E11–13). A mutant variant was de-
tected that lacked exons 12–21 but which containedregulator of gene expression.
To investigate the importance of the Mi-2 chromatin downstream sequences (Figure 1C, E30–34). The pres-
ence of Mi-2 protein was examined using a monoclonalremodeling complex in T cell development, we condi-
tionally inactivated Mi-2 (CHD4), the most abundantly antibody that detects an epitope in exon 11, which lies
upstream of the deleted region. A dramatic reduction inexpressed of the two Mi-2 homologs, in thymocytes.
We show that Mi-2 functions as a positive regulator of the amount of full-length Mi-2 protein was seen in the
thymus (Figure 1D). A truncated Mi-2 protein was notthe DN to DP transition and of TCR-mediated prolifera-
tive responses in mature T cells and provide unexpected detected (data not shown), suggesting that it was either
not produced by the mutant mRNA or that it was notevidence that Mi-2 is involved in the positive regulation
of CD4 expression in differentiating DP thymocytes. stable. Further examination of purified thymocyte sub-
sets revealed that Mi-2 protein was significantly re-Mi-2 is found associated with the CD4 enhancer in
CD4-expressing cells, and recruitment of the p300 his- duced in the Mi-2F/F (KO) DN population, was further
reduced in DP cells, and was virtually absent in the CD8tone acetyl transferase and the HEB transcription factor
to the enhancer is Mi-2 dependent. and CD4 SP populations (Figure 1E).
We also examined expression of the second Mi-2 fam-
ily member, Mi-2, which shares strong homology withResults
Mi-2. Whereas the level of Mi-2 is very low in the wild-
type (wt) thymus, it was upregulated in the KO thymusConditional Inactivation Strategy for the Mi-2 Locus
(Figure 1D). The increase in Mi-2 protein levels re-To examine the role of Mi-2 during development, we
flected an upregulation of Mi-2 mRNA that was de-generated mice that carry Cre-recombinase recognition
tected in all thymocyte subsets from the DN throughsignals (LoxP sites) upstream of exon 12 and down-
the DP to the SP stages of differentiation (Figure 1C,stream of exon 21 (Figure 1A). Deletion of exons 12–21
Mi-2).from the Mi-2 locus removes the ATPase domain,
In contrast to Mi-2, the levels of other componentswhich is required for its remodeling activity. Splicing of
of the NuRD complex, i.e., HDAC2 and RbAp48, as wellexon 11 to exon 22 would be expected to generate an
as Ikaros and Aiolos, which constitute components ofout of frame mRNA, possibly resulting in a truncated
a lymphoid version of the NuRD complex, were not al-protein. The originally modified Mi-2 locus also con-
tered by the Mi-2 deletion (Figure 1D and data nottained the pgk-neomycin expression cassette, flanked
shown). Brg-1, the ATPase subunit of the SWI/SNF re-by FLP recombinase signals (Frt sites; Figure 1A, Mi-
modeling complex, and the nuclear factor YY1 were also2LoxPNeo). To avoid interference effects on expression
present at normal levels.of Mi-2, the pgk-neo gene was deleted in the mouse
germline by crossing onto an actin-FLP transgenic line
(Dymecki, 1995). The flipped Mi-2 locus was desig- Mi-2 Inactivation Interferes with CD4 Expression
in DP Thymocytesnated as Mi-2LoxPF (Figure 1A). To inactivate Mi-2 dur-
ing T cell development, mice homozygous for the Mi- Analysis of Mi-2 KO mice revealed a consistent reduc-
tion in thymus cellularity compared to wt or heterozy-2LoxPF allele and carrying an Lckpr (Lck proximal pro-
moter)-Cre transgene were generated (Figure 1A, Mi- gous littermates, regardless of whether the Mi-2LoxPF
target was biallelic or monoallelic. In all KO mice ana-2F). This Lckpr-Cre transgene is active from the double-
negative (DN) stage of T cell differentiation to mature lyzed (n  40), a similar change in thymocyte profiles
was detected relative to wt (Figure 2B). The percentageT cells (Lee et al., 2001). We also generated a germline
deletion of the ATPase domain designated as Mi-2 of DP thymocytes was severely reduced, whereas CD8
cells were greatly increased in a “compensatory” fash-that was combined with the Mi-2LoxPF allele and the
Lckpr-Cre transgene. In both Mi-2/LoxPF and Mi- ion. DP and CD4SP thymocytes expressed lower levels
of CD4 (Figures 2B and 2C), and CD8 cells ranged from2LoxPF/LoxPF strains, Lckpr-Cre-mediated deletion in thymic
T cells was calculated to occur at95% frequency (Fig- CD4lo to CD4. As DN thymocytes mature to become DP,
they progress through a transient immature intermediateure 1B). In the periphery, although a significant number
of T cells had undergone deletion, an undeleted fraction single-positive (ISP) stage during which CD8 is ex-
pressed without CD4 (Figure 2A). ISPs express little orwas also observed (Figure 1B).
RNA analysis of thymocyte subsets in which Mi-2 no TCR or CD5 and express high levels of HSA. The
CD8 populations that accumulate in the KO could bewas conditionally inactivated indicated that the produc-
tion of full-length Mi-2mRNA was dramatically reduced arrested ISPs, DPs that lack CD4, or mature SP CD8
cells. Markers that do not rely on CD4 expression and arein DN and DP thymocytes and was absent in CD8CD4lo
(C) Reduction of full-length Mi-2 mRNA in thymic subpopulations. RNA was extracted from KO and Mi-2/ thymic subpopulations based
on CD4 and CD8 expression (Figure 2B). RT-PCR was performed with primers spanning exons 11–13 (within the deleted region) or exons
30–34 (downstream of the deletion region) of the Mi-2 gene, exons 29–32 of the Mi-2 gene, or -actin gene as a control. Two dilutions of
cDNA (neat, 1:5) were used for each sample.
(D) Western blot analysis of thymus nuclear extracts from wt (Mi-2/), heterozygote (Mi-2/F), and Mi-2-deficient (Mi-2F/F) littermates.
The antibodies used are indicated. YY1 protein levels are shown as a loading control.
(E) Western blot analysis of Mi-2 expression in whole-cell extracts from Mi-2/ (wt) or Mi-2F/F (KO) thymus subpopulations. Thymocytes
were sorted into the indicated populations as described in (C). Ikaros and YY1 protein levels are also displayed.
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differentially expressed during the DN to SP progression (Figure 2D). Expression of the apoptotic factor Fas is
normally low in the immature DN and mature SP but iswere used to distinguish these possibilities (Figure 2A).
Thymocytes upregulate TCR expression as they prog- upregulated in DP to allow for appropriate selection of
the TCR repertoire at this stage of differentiation (Figureress from the DN (TCR/lo) through the DP (TCRintermediate)
to the SP (TCRhigh) stages of their differentiation (Figures 2A) (Linette et al., 1994; Strasser et al., 1995). The anti-
apoptotic factor Bcl-2 displays a complementary ex-2A and 2B, Mi-2/). Despite an increase in CD8-
expressing cells, the overall T cell receptor (TCR) ex- pression profile to Fas (Figure 2A). The DN, DP, and
CD4 SP thymocyte subsets in the KO thymus exhibitedpression profile was not dramatically altered in the
Mi-2-deficient thymus (Figure 2B), suggesting that de- similar Fas and Bcl-2 expression to their wt counterparts
(Figure 2C). In KO CD8CD4 cells, Fas expression wasvelopmental progression was largely normal. To assess
the maturity of the overrepresented CD8 population in higher and Bcl-2 expression was lower than normally
detected at this stage of differentiation, and both werethe KO, thymocytes were subgated based on CD4 and
CD8 expression. Within the KO subsets, the expected comparable to wt DP levels (Figure 2C). Collectively,
phenotypic analysis of thymocytes strongly supportsincrease in TCR was detected from DN to DP to CD4
SP subsets (Figure 2B, TCR). Strikingly, the majority that the majority of CD8CD4 and CD8CD4lo cells that
accumulate upon Mi-2 deletion are DP that have failedof the CD8-expressing KO thymocytes expressed TCR
levels comparable to the wt DP population (Figure 2B to express appropriate levels of CD4.
and Supplemental Figure S1 at http://www.immunity.
com/cgi/content/full/20/6/719/DC1). Very few of the KO Thymocyte Apoptotic Properties Remain Unaltered
in the Absence of Mi-2CD8 cells were TCR/lo, suggesting that the majority
were not ISP (Supplemental Figure S1 on Immunity’s In the KO thymus, the percentage of DP and DP-like
(CD8CD4, CD8CD4lo) populations sum to 79%,website). A small number of CD8/TCRhi SP were also
detected (Supplemental Figure S1, TCRhi gate), but which is within the expected range for DP in the wt
(Figure 2B). Since thymus cellularity was reduced 3-most of the aberrant CD8-expressing thymocytes were
not mature SP cells. Intermediate “DP-like” levels of fold in the KO, the absolute number of DP cells was also
reduced3-fold. Thus, we examined whether there wasthe CD5 marker, which parallels TCR expression during
thymocyte differentiation but is not dependent on rear- an increase in apoptosis within the KO thymocytes that
could account for the decrease in thymus cellularity.rangement events, were also detected on the Mi-
2-depleted CD8CD4/lo populations (data not shown). Sorted thymocyte subpopulations were stained with
Annexin V and propidium iodide (p.i.). No significantThe CD8-expressing thymocytes that accumulated in
the KO thymus were therefore DP-like in their intermedi- difference in apoptotic cells (AnnexinV) or dead cells
(AnnexinV/PI) was detected within the DP subpopula-ate expression levels of TCR and CD5.
Thymocyte populations were also evaluated using the tions of the wt and KO thymus (Supplemental Figure
S2A, available on Immunity’s website, DP). A small in-HSA marker (Figure 2B, HSA). HSA is normally ex-
pressed at highest levels within the late DN compart- crease in apoptotic cells was detected within the
CD8CD4 and CD8CD4lo subsets upon Mi-2 deletionment (DN3 and DN4). It is then progressively downregu-
lated through thymocyte differentiation (Figures 2A and (Supplemental Figure S2A on Immunity’s website). The
higher apoptotic index of these populations in the KO2B, wt). Among the KO thymocyte subsets, the expected
decrease in HSA levels was detected from DN to DP to compared to the wt in part correlates with their proposed
DP nature. Nonetheless, the majority of these CD8 cellsCD4 SP subsets (Figure 2B, KO). However, the majority
of the CD8-expressing populations in the KO thymus were not apoptotic. Apoptosis was also examined using
the TUNEL assay on thymic sections. A similar numberexpressed HSA at a level similar to that of the DP and
not the CD8 ISP or CD8 SP cells (Figure 2B), sug- of apoptotic cells was seen in wt and in KO thymic
sections (data not shown). Thus, loss of Mi-2 and thegesting that, despite their lack of CD4 expression, they
otherwise resemble wt DP. reduction of CD4 expression on DP and SP thymocytes
has no significant effect on their ability to die by apo-The “identity” of the CD8CD4/lo populations was
further examined by RT-PCR analysis of Fas and Bcl-2 ptosis.
Figure 2. Mi-2 Inactivation Alters Thymocyte Differentiation
(A) Schematic representation of developmental transitions and gene expression during T cell development in the thymus. Expression of CD4
and CD8 coreceptors; relative levels of cell surface markers TCR, CD5, and HSA; and pro- and antiapoptotic genes Fas and Bcl-2 are indicated.
(B) Mi-2 deletion leads to dysregulation of CD4 expression in DP thymocytes. Three color FACS analysis of thymus profiles from 5 weeks
wt and Mi-2F/F littermates are shown. Dot plots display CD4 versus CD8 expression and numbers beside each box indicate the percentage
of cells in each subpopulation. Thymus cellularity is indicated. Thymocytes from wt (green) or KO (red) littermates were sorted into five
populations (DN, DP, CD8CD4lo, CD8CD4, CD4). Expression of TCR and HSA in the five populations is displayed as single color histograms.
Dotted lines representing mean fluorescence intensity (MFI) in each sample are included for comparison. Two dotted lines appear overlaying
the wt CD8CD4 histogram. These represent the CD8 SP (HSAlo, TCRhi) and ISP (HSAhi, TCRlo) populations that are normally found within
this subset. Note that the MFI for HSA expression in the KO CD8CD4 population falls between the wt ISP and wt CD8 SP peaks and is
similar to that of DP.
(C) Expression of CD4 protein and mRNA is reduced in Mi-2F/F thymocytes. CD4 surface expression in three sorted populations of thymocytes
wt or KO littermates is displayed as single color histogram overlays (wt/green; KO/red). Dotted lines represent MFI. RNA was prepared from
the same sorted thymocyte populations, then RT-PCR was performed with primers specific for the CD4 gene. -actin level is shown as a control.
(D) Mi-2-deficient CD8 thymocytes resemble DP in their expression of Fas and Bcl-2. RT-PCR was performed with primers specific for Fas
and Bcl-2 using RNA prepared from four sorted subpopulations (DN, DP, CD8CD4, CD4) and thymus from wt and KO littermates.
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The DN to DP Transition Is Impaired 5-fold reduction in T cells was noted in the spleen and
lymph nodes, with a similar decrease evident in bothupon Mi-2 Deficiency
Despite the significant decrease in thymocyte cellularity the CD4 and CD8 populations (Figure 4A). The mutant
DP thymocytes were therefore able to differentiate intocaused by Mi-2 deletion, the absolute number of DN
thymocytes was unaltered if not elevated (Figure 3A). CD4 and CD8 T cells and seed the periphery, sug-
gesting that a fraction of these cells undergo maturationTo further examine the effect of the Mi-2 mutation at
the DN stage of differentiation, thymocytes were gated and selection events. Similar to the thymus, mutant
CD4 T cells in the periphery expressed lower levels offor Lin/Thy1, and their distribution into the DN1-DN4
populations was examined. A decrease in the DN3 and CD4 (Figure 4A).
T cells respond to engagement of their antigen recep-an increase in the DN4 population were seen reproduci-
bly among KO thymocytes (Figure 3B). Expression of tors by proliferating. To assess the proliferative capacity
of KO T cells, the Lck-Cre/Mi-2 strain was bred ontoTCR as an intracellular (IC) protein can be detected
between the DN3 and DN4 stages of development, and a GFP reporter of Cre activity (Novak et al., 2000), and
GFP cells were sorted and used for in vitro proliferationsignaling through the pre-TCR complex is responsible
for triggering this developmental transition. The majority assays. PCR analysis confirmed that95% of the GFP
cells had deleted Mi-2 (Figure 4B). A 5- to 7-fold de-of DN4 cells in both the wt and KO thymi expressed IC-
TCR although a larger population of negative cells was crease in 3H-thymidine incorporation was observed for
KO T cells relative to wt 48 hr after TCR/CD3 stimulation,reproducibly seen in the KO (Figure 3C). At the DN3
stage, a small population of IC-TCR cells was de- indicating that fewer KO T cells were in S phase (Figure
4B). KO T cells expressed normal levels of the TCR/CD3tected in wt, which was again reduced in the KO (Figure
3C). Evaluation of mRNA expression of pre-TCR signal- complex (data not shown). A proliferation defect was
also seen with PMA and calcium ionophore, which by-ing components like pT and TCR transcripts did not
reveal any significant difference between the wt and pass proximal TCR signaling events and directly activate
protein kinase C signaling. A relatively small increase inKO DN3 and DN4 populations (data not shown). The
percentage of cycling cells and their profiles were similar apoptotic and dead cells was seen 48 hr after activation
with KO T cells (Supplemental Figure S2 on Immunity’sbetween the DN populations in KO and wt (Figure 3C).
More dead cells were detected within the KO DN3 and website), but the majority of cells were alive. The ability
of KO- and wt-activated T cells to go through consecu-DN4 although the majority of cells in these populations
were viable (Figure 3C). tive cell divisions was also evaluated by CFSE labeling.
A progressive decrease in cycling T cells was seen fromDevelopmental transitions can be better evaluated in
the late fetal thymus where the differentiation of one the second to the third cell division and is consistent
with the lower 3H-thymidine incorporation (Figure 4C).rather than of several asynchronously entering waves
of precursors is detected. In the late fetal/neonatal wt In addition, a larger number of nonblast T cells that
retained high levels of CFSE, suggesting failure to enterthymus the majority of precursors have developed to
the DP stage of differentiation (Figure 3D, Mi-2/). In the cell cycle, were observed. TCR engagement of KO
T cells induced expression of activation markers, likesharp contrast, in the KO thymus, the majority of cells
remain at the DN stage (Figure 3D, Mi-2/) and are CD25 and CD69, but an increased number of negative
cells were detected (Figure 4D).blasting (Figure 3D, FSC), consistent with being imma-
ture cycling cells. Further analysis of the mutant DN Thus, Mi-2 deficiency has two effects on T cell prolif-
eration: it causes both a reduction on the number ofpopulations revealed an accumulation of DN4 cells (Fig-
ure 3D) similar to what was seen in the adult. T cells that become activated and of those that can
proceed through successive cell divisions efficiently.Mi-2 is thus required for normal transition from the
late DN (DN4) to the DP stage of differentiation subse-
quent to  selection. In the absence of Mi-2, differenti- A CD4-Based Transgene Relies
ating thymocytes appear to stall at the DN4 stage, but on Mi-2 for Expression
some of them eventually make the transition to DP. This During T cell development, CD4 expression is coordi-
inefficient precursor transition is likely responsible for nately regulated by positive and negative elements sur-
the reduction in total thymocyte cellularity. Upregulation rounding the CD4 locus, namely a proximal enhancer
of other homologous factors at the DN4 stage, such as (Sawada and Littman, 1991), silencer (Sawada et al.,
Mi-2 (Figure 3C), may partially rescue the DN-DP tran- 1994; Siu et al., 1994), and LCR/3 DP enhancer working
sition. in combination with the proximal enhancer (Adlam et
al., 1997; Adlam and Siu, 2003). Collectively, our data
indicate that Mi-2 may be acting through these regula-The Role of Mi-2 in TCR-Mediated
Proliferative Responses tory elements to activate the CD4 locus.
We have begun to examine the effect of Mi-2 muta-The ability of KO thymocytes to mature to the SP stage
was evaluated. Gating on TCRhigh cells in the thymus tion on the activity of these regulatory elements using
a GFP transgenic reporter. In the absence of the silencer,revealed a relative decrease in CD4 SP and, conse-
quently, a relative increase in CD8 SP thymocytes, al- a CD4 enhancer-promoter-GFP cassette (Manjunath et
al., 1999) expresses at high levels in all thymocyte sub-though this could be due to an overflow of TCRint DP-
like cells in the TCRhi gate (Supplemental Figure S1 on sets, including DP, but not in non-T cells (Figure 5, wt).
Mi-2 depletion caused a reduced GFP expression inImmunity’s website, TCRhi gate). The ability of Mi-2-
deficient CD4 and CD8 SP cells to exit the thymus all subpopulations compared to wt (Figure 5, KO). Impor-
tantly, GFP levels were most reduced in CD8CD4lo andand accumulate in the periphery was examined. A 2- to
Activation of CD4 Requires Mi-2
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Figure 3. Effects of Mi-2 Deficiency on the DN to DP Transition
(A) Bar graph summary of cell numbers and percentages of total thymocytes and DN populations in KO (n  24) versus wt (n  26).
(B) DN1-DN4 profiles in the adult wt and KO thymus. Lin/Thy1 thymocytes were examined for expression of CD44 and CD25, revealing an
increase in the mutant DN4 population.
(C) DN3 (CD44/CD25) and DN4 (CD44/CD25) populations were sorted and analyzed for expression of IC-TCR, cell cycle profile (propidium
iodide), and apoptosis (AnnexinV/propidium iodide). mRNA was prepared from the same sorted subsets, and expression of Mi-2 (exons
11–13), Mi-2, and -actin was determined.
(D) Temporal block at the DN stage of differentiation in neonatal thymus of Mi-2 KO. In contrast to wt, the majority of mutant thymocytes
show a high FSC reflecting an immature blasting state. Further analysis of DN thymocytes (as in [B]) revealed an accumulation of DN4 (CD44/
CD25) cycling cells in the KO.
CD8CD4 cells, mirroring the progressive loss of Mi-2 effect of Mi-2 depletion was also examined on the
Rosa26-YFP transgene to determine whether it affected(Figures 1C and 1E) and decrease in endogenous CD4
expression (Figures 2B and 2C) in these subsets. The other unrelated regulatory regions in a similar fashion.
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Figure 4. T Cell Maturation in the Absence of
Mi-2
(A) Mi-2-deficient mice exhibit a reduction
in peripheral T cells. CD4 and CD8 staining
on peripheral LN from 6-week-old wt and KO
littermates is shown. The total LN cell count
for each animal and the percentage of cells
in each quadrant is shown. An arrowhead
points to the MFI of CD4 expression in each
animal. Arrowheads indicating that CD8 fluo-
rescence is unchanged are included as a
control.
(B) Mi-2-deficient T cells are hypoprolifera-
tive. Since Mi-2 deletion was 	100% in pe-
ripheral T cells, Lckpr-Cre/Mi2LoxPF/LoxPF mice
were crossed to the LacZ/EG indicator strain
in which cells actively expressing Cre re-
combinase are marked by GFP expression.
GFP LN cells were then sorted that were
either Lckpr-Cre/Mi2/ (wt) or Lckpr-Cre/
Mi2LoxPF/LoxPF (KO). Mi-2 deletion efficiency
in Lckpr-Cre/Mi2LoxPF/LoxPF GFP T cells
(95%) is displayed in the PCR panel on the
right. The GFP T cell pool also contains a
fraction of Mi-2F/F T cells, suggesting that
GFP expression in the indicator line lags be-
hind Cre activity. LN or GFP T cells were
activated in vitro with either -CD3 or PMA
and ionomycin. Bar graphs of the scintillation
counts represent the relative proliferation in-
dex for the wt or KO cells.
(C) Inability of activated Mi-2F/F T cells to
go through normal cell divisions is revealed
by FACS analysis of a combination of CFSE
labeling and cell size (FSC). The overlay of
CFSE staining of wt versus KO T cells at 48
hr after activation shows a difference in the
fraction of cycling cells.
(D) Induction (0 to 48 hr) of activation markers
(CD25 and CD69) in Mi-2F/F T cell activa-
tion cultures.
The Rosa26-YFP transgene is expressed throughout 6C; Mi-2/). Anti-Mi-2 Abs reproducibly gave strong
enrichment at the proximal enhancer compared to con-T cell differentiation with its levels showing an increase
from the DP to the SP stage (Figure 5). wt and mutant trol Abs (Figure 6B and Supplemental Figure S3A on
Immunity’s website, Mi-2/). Only low levels of enrich-DN, DP, and CD4 SP thymocytes expressed similar
levels of the Rosa26-YFP reporter. Mutant CD8/CD4lo ment were detected over the promoter and LCR/3 en-
hancer regions. The strong proximal enhancer enrich-and CD8/CD4 thymocytes expressed lower levels of
the reporter consistent with their DP state of differentia- ment was lost in the KO thymus (Figures 6B and 6C,
Mi-2F/F).tion. Therefore, in the context of a transgenic reporter,
Mi-2 is specifically affecting the activity of the CD4 These findings provide evidence for a direct and spe-
cific association between Mi-2 and the CD4 proximalenhancer-promoter elements.
enhancer that is required for CD4 gene regulation during
T cell differentiation. They suggest that the changesA Direct and Specific Association between Mi-2
and the CD4 Enhancer observed in thymocyte profiles in the KO reflect direct
involvement of Mi-2 in modulating the chromatin stateTo test the hypothesis that Mi-2 directly regulates CD4
expression through its association with CD4 regulatory of CD4 regulatory elements.
elements, we performed chromatin immunoprecipita-
tions (ChIP) on wt thymus, as85% of the cells express Recruitment of HAT Activities to the CD4
Regulatory Elements Requires Mi-2CD4. After ChIP with anti-Mi-2 antibodies (Abs), a mul-
tiplex PCR was performed to evaluate the specific en- Next, we evaluated the histone acetylation state of the
CD4 regulatory regions in the presence and absencerichment of each regulatory element (Figures 6B and
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Figure 5. Mi-2 Is Required for Developmentally Regulated Expression of a CD4 Transgenic Reporter
Decreased expression of an exogenous GFP-expressing CD4 transgene in Mi-2-deficient thymocytes. Five thymocyte subpopulations were
identified based on CD4 and CD8 expression in the wt and KO thymus (see gates, top). Expression levels of the T-GFP-CD4 transgene
(Manjunath et al., 1999) are shown as overlaid histograms within these subsets (wt, green; KO, red). Expression of a Rosa26-YFP trans-
gene in KO thymocyte subpopulations is provided as a control for specificity of the Mi-2 deficiency effect on expression of the CD4-transgene.
Dotted lines indicate the MFI in each of the subpopulations in the T-GFP-CD4 and Rosa26-YFP transgenes.
of Mi-2. High levels of histone H3-acetylation (AcH3), the CD4 enhancer in thymocytes that is likely responsi-
ble for the histone hyperacetylation at this region.which are generally associated with gene activation,
were detected at the proximal enhancer in the wt thymus
(Figures 6B and 6D). Significant AcH3 was also detected Mi-2 Promotes HEB Recruitment
to the CD4 Enhancerat the CD4 promoter (Figures 6B and 6D), possibly re-
flecting recruitment of HAT-containing transcription ini- The CD4 enhancer has binding sites for E box proteins,
which are critical for its activity (Sawada and Littman,tiation complexes (Mizzen et al., 1996). AcH3 was pres-
ent at much lower levels in other regions of the gene 1991) and are bound by HEB and E2A-related transcrip-
tion factors in vitro (Sawada and Littman, 1993). Similar(i.e., exon 10 and 3 LCR/enhancer) (Figures 6B and 6D).
A great reduction in AcH3 at the proximal enhancer and to the Mi-2F/F phenotype, HEB knockout leads to ac-
cumulation of CD8-expressing immature thymocytes, apromoter was seen in the KO thymus (Figures 6B and
6D). We thus hypothesize that Mi-2 specifically associ- significant fraction of which resemble DP cells (Barndt
et al., 1999). We therefore investigated whether HEBating with the CD4 proximal enhancer changes chroma-
tin structure that allows recruitment of HATs. bound to the CD4 enhancer in vivo and whether this
binding was affected by lack of Mi-2. Abs to HEBWe examined which of the previously described HATs
was responsible for CD4 enhancer hyperacetylation. showed very strong enrichment for the CD4 enhancer,
which was drastically reduced upon Mi-2 depletionAnti-p300 Abs showed strong enrichment of the proxi-
mal enhancer but not of other regions of the CD4 gene (Figure 7B). Since Mi-2 deficiency did not alter HEB
transcription (data not shown), these findings indicate(Figure 7A, Mi-2/). Significantly, the association of
p300 with the enhancer was reduced in the absence Mi-2 remodeling activity at the CD4 enhancer enables
strong HEB binding.of Mi-2 (Figure 7A, Mi-2F/F). CBP, a protein closely
related to p300, and other tested HATs (PCAF, Gcn5,
and Tip60) showed little or no discernible enrichment A Physical Association between Mi-2, p300, and HEB
The physical interactions between Mi-2, p300, and HEB(data not shown). Although we cannot exclude the possi-
bility that the detection of some of these factors with were evaluated. Immunoprecipitation of p300 from thy-
mocytes, whether in the absence or presence of ethid-ChIP is limited by the antibody used, these studies iden-
tify a specific Mi-2-dependent association of p300 with ium bromide, revealed a DNA-independent association
Immunity
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Figure 6. Mi-2 Association and Histone H3 Acetylation of CD4 Regulatory Elements
(A) Schematic representation of the CD4 locus. Exons around the CD4 locus are shown in the upper half, and the known CD4 regulatory
elements are indicated in the bottom half of the gene.
(B) Results of -Mi-2 and -AcH3 ChIP. Chromatin samples from wt (upper panels) or Mi-2KO (lower panels) thymocytes were immunoprecipi-
tated using control mouse IgG, -Mi-2, or -AcH3. Coprecipitated DNA was analyzed by multiplex PCR. In each panel, the upper bands are
from the region of interest, whereas the bottom bands (asterisks) are internal controls from an irrelevant genomic region. Fold enrichment
relative to IgG ChIP was calculated as described (Harker et al., 2002). Relatively strong enrichment of the proximal enhancer and to a lesser
extent, the promoter, was obtained with -Mi-2 and -AcH3. Enrichment was diminished in the KO sample, indicating dependence on the
presence of Mi-2.
(C) Graphical presentation of the calculated fold enrichment for -Mi-2 ChIP from (B). The results for the wt and KO are plotted with black
and gray boxes, respectively.
(D) Fold enrichment for -AcH3 ChIP from (B) is plotted as (C).
of p300 with Mi-2 and HEB but not with HDAC2 (Figure ure 7C). Thus, the ability of Mi-2 to physically associate
with p300 and HEB is likely important for their recruit-7C). Immunopurification of Flag-Mi-2 from thymocytes
also revealed its association with p300 and HEB (Figure ment to the CD4 enhancer, a necessary step for subse-
quent hyperacetylation and transcriptional activity of7C). Finally, immunoprecipitations with anti-HEB Abs
confirmed HEB’s association with Mi-2 and p300 (Fig- this locus.
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Figure 7. Mi-2 Promotes Recruitment of HEB and p300 to the CD4 Enhancer
(A) p300 HAT association with the CD4 regulatory regions. ChIP was performed using -p300. The results of the multiplex-PCR analyses for
the proximal enhancer, promoter, exon 10, LCR, and 3 enhancer are shown. Asterisks indicate the internal control. Calculated fold enrichment
of p300 association with the CD4 regulatory region is shown on the right as a bar graph. -p300 gave strong enrichment at the first half of
the proximal enhancer, which was abolished in the KO.
(B) HEB association with the CD4 enhancer is Mi-2 dependent. ChIP analysis with -HEB was performed as described in (A). Given the very
strong association of HEB with the enhancer, PCR reactions for the target and internal control were performed separately and a 1:9 dilution
of the template was used for target amplification.
(C) Immunoprecipitations of thymocyte nuclear extracts with -p300 ( and  ethidium bromide), -HEB, or IgG control and of thymocyte
nuclear extracts expressing flag-tagged Mi-2with -flag followed by elution and Western blotting with -p300, -Mi-2, -HEB, and -HDAC2
reveal a physical association between HEB, p300, and Mi-2 but not HDAC2.
Discussion in the thymus through its direct interactions with the
CD4 enhancer as well as the HAT p300 and the E box
binding protein HEB.In this study, we examine the role of the chromatin re-
modeler Mi-2 during T cell differentiation by condition-
ally inactivating the gene in mice. We show that Mi-2 Mi-2 Is Required for Normal Expression
of CD4 during T Cell Developmentactivity is required in at least three distinct stages of
T cell development: in late DN to support their transition Conditional inactivation of Mi-2 during T cell develop-
ment produced a dramatic decrease of DP thymocytes,to the DP stage, in DP for normal expression of the
CD4 coreceptor, and finally in mature T cells for their which represent the majority in the wt thymus. The de-
crease was accompanied by a compensatory increaseproliferative expansion (Figure 8A). Using independent
genetic approaches and biochemical studies, we pro- in CD8-expressing thymocytes, which were equally
distributed between the CD8CD4 and CD8CD4lo sub-vide unexpected evidence that Mi-2 is involved in the
positive regulation of the CD4 gene during differentiation populations. Further characterization of the Mi-2-
Immunity
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Functional Dependence of the CD4
Enhancer on Mi-2
A proximal enhancer in the CD4 locus acts upon its
promoter to confer a high level of gene expression at
all stages of T cell development (Sawada and Littman,
1991). The dependency of these positive CD4 regulatory
elements on Mi-2 was studied. An Mi-2 dependence
of the CD4 proximal enhancer was shown in the context
of a transgenic reporter. Reporter expression was most
dramatically reduced in the DP-like populations, paral-
leling the observations made with the endogenous CD4
locus. The effect was specific for the CD4-driven GFP,
as a GFP reporter under the control of distinct regulatory
elements exhibited no change in expression upon Mi-
2 depletion. These studies support the hypothesis that
the CD4 enhancer depends on Mi-2 for its activity,
whether in the context of the endogenous CD4 locus or
as a transgene.
Mi-2 Controls the Transition from DN to DP
Subsequent to  Selection
Mi-2 is also required for the transition of DN thymo-
cytes to the DP stage of differentiation. Although DP
thymocytes and their SP progenies are consistently re-
duced relative to wt, the number of DN thymocytes is
if anything elevated. There appears to be an increase
Figure 8. The Role of Mi-2 in T Cell Development and a Model on
in both the relative but also absolute representation ofCD4 Gene Regulation
DN4 cells both in the adult and in the late fetal stage.
(A) A summary of the effects of Mi-2 depletion on T cell develop-
In the late fetal thymus, a severe block between DN andment. X indicates a block in DN differentiation, defect in CD4 gene
DP is detected, with very few cells progressing to DPexpression, and a defect in antigen receptor-mediated proliferative
expansion of SP T cells. “/” shows severe reduction in CD4 and the majority of cells poised at DN4. As these mutant
expression on DP and a downward arrow lower levels of CD4 ex- DN4 cells express IC-TCR and pT, the effect of Mi-2
pression on CD4 SP T cells. deficiency manifests downstream of  selection. The
(B) Mi-2 and p300 interacting with HEB are recruited to HEB cog- lack of Mi-2 therefore has a dramatic effect in the devel-
nate sites (E box sites) on the CD4 enhancer. Mi-2 promotes chro-
opment of fetal thymocytes, which postnatally appearsmatin fluidity in an ATP-dependent fashion and stabilizes HEB bind-
to be partially alleviated. Upregulation of the seconding. The presence of p300 in complex with either HEB or Mi-2
or both induces local histone hyperacetylation (flags) that locks family member Mi-2 at the DN4 stage may in part com-
chromatin in an open configuration. Interactions between the acti- pensate for Mi-2 deficiency and rescue some but not
vated enhancer and the CD4 promoter (broad arrow) stabilize re- all of the DN4 precursors to the DP stage.
cruitment of basal transcription factors resulting in CD4 gene ex- Given prevailing models of T cell differentiation, which
pression.
support that selected thymocytes transit to DP without
any further restriction, these studies on Mi-2-deficient
thymocytes provide us with insight into regulatorydepleted thymocytes using a battery of T cell develop-
events that take place at the DN4 stage and are requiredmental markers indicated that the majority of CD8 cells
for further differentiation. Mutations in the TCF/LEF nu-were DP thymocytes that failed to express appropriate
clear effectors of the Wnt signaling pathway, in the Elevels of CD4. Mi-2-depleted CD8 thymocytes ex-
box gene HEB, and in the chromatin remodeler Brg-1pressed intermediate levels of TCR, CD5, and HSA; high
also affect the late DN to DP transition (Barndt et al.,levels of Fas; and low levels of Bcl-2, a gene expression
1999; Chi et al., 2003; Schilham et al., 1998). Biochemicalprofile normally associated with DP. A decrease in CD4
studies described here provide evidence that Mi-2 andsurface expression was detected in Mi-2-deficient DP
HEB work together to regulate CD4 gene expressionand to a smaller extent in CD4 SP T cells in the thymus
during T cell differentiation. It will therefore be importantand in the periphery, which correlated with a reduction
to examine further which of these factors belong to thein CD4 mRNA. Thus, reduction in Mi-2 levels affects
same regulatory pathway operating in late DN and tothe ability of DP thymocytes to activate or maintain ex-
identify their gene targets that control this develop-pression of CD4, and they range phenotypically from
mental process.CD8CD4intermediate to CD8CD4lo to CD8CD4. Taken to-
gether, these studies support the hypothesis that during
T cell differentiation, CD4 expression relies on Mi-2 Mi-2 Is Required for Normal T Cell Proliferation
Mi-2-depleted peripheral T cells are unable to undergoactivity. Alternative mechanisms operating in DP and
CD4 SP T cells, i.e., an increase in expression of the normal proliferation, implicating Mi-2 as a positive reg-
ulator in this process. Although antigen receptor en-family member Mi-2, may provide compensation for
the lack of Mi-2 and rescue CD4 expression, albeit to gagement in these mutant T cells upregulated activation
(G1) markers like CD25 and CD69, the number of cellslower levels.
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in S phase, measured by 3H-thymidine incorporation, Mi-2:HAT:HEB complexes to the enhancer promotes
positive rather than negative events in gene expression.was reduced. CFSE labeling also revealed a progressive
reduction in mutant T cells in successive cell divisions. Recently, a 3 enhancer/LCR was described in the
CD4 locus. These regulatory regions together with theMi-2 may play a role in chromosome propagation, for
example as part of the cohesin complex (Hakimi et al., proximal enhancer were shown to support CD4 expres-
sion in DP thymocytes (Adlam et al., 1997). No significant2002), and its absence may result in chromosome aber-
rations. This may cause cycling cells to abort their divi- association between Mi-2 and this regulatory region
was detected. The islands of histone H3 hyperacetyla-sion, causing their progressive decrease at later cell
cycles. The increase in apoptotic cells seen in the mutant tion, caused by Mi-2 recruitment to the CD4 regulatory
regions, were also not observed over the 3 enhancer/activation cultures may represent such aborted cell cy-
cle events consistent with this working hypothesis. LCR. Taken together, these results support that the
Mi-2 effects on CD4 expression are mediated through
its interactions with the proximal enhancer and notRecruitment of HEB, p300 HAT to the CD4 Enhancer
through the 3 enhancer/LCR.and Enhancer Hyperacetylation Is
Dependent on Mi-2
The E box transcription factor HEB has been implicated A Model of CD4 Regulation by Mi-2
Based on the above findings, we propose the followingas an activator of CD4 expression working through the
CD4 enhancer (Sawada and Littman, 1991). Interest- working model on how Mi-2 activates CD4 gene ex-
pression (Figure 8B). First, Mi-2 is recruited to the CD4ingly, HEB deficiency, like Mi-2 inactivation, partially
impairs the DN to DP transition and causes the accumu- enhancer, presumably through its HEB interactions.
Mi-2 then provides ATP-dependent chromatin fluiditylation of CD8-expressing cells with DP characteristics
(Barndt et al., 1999). Our ChIP experiments show a and stabilizes HEB binding. The HAT p300 either through
its association with Mi-2 or HEB is also recruited atstrong and specific association between HEB and the
CD4 enhancer that is dependent on Mi-2. the CD4 enhancer and locks the chromatin into an open
configuration by increasing the local histone acetylation.Further chromatin studies have revealed the existence
of islands of histone hyperacetylation on the enhancer Activation of the CD4 enhancer precipitates binding of
basal transcription factors and their associated HATsand to a lesser extent on the promoter but not through-
out the CD4 locus. This suggests that hyperacetylation to the promoter, leading ultimately to CD4 expression.
Inactivation of Mi-2 decreases the frequency withis a specific regulatory event and not a mere reflection
of active transcription. Mi-2 deficiency caused a reduc- which these regulatory events occur, causing variable
and reduced expression of the CD4 locus.tion in histone hyperacetylation of the CD4 enhancer
and promoter. Other regions of the CD4 locus that were As a chromatin remodeler, Mi-2 functions as a cata-
lyst of chromatin fluidity. Because of its association withmodestly acetylated remained unaffected upon Mi-2
depletion. Thus, the Mi-2 effect on hyperacetylation of HDACs, Mi-2 has been presumed to be involved in
establishing a repressive chromatin structure. However,the CD4 enhancer and promoter is specific for these
regions and not a global effect on chromatin. Mi-2 may also function outside the NuRD complex.
Recent studies have shown that Mi-2 may be involvedIn search of the HAT that hyperacetylates the CD4
regulatory regions, we have established a specific asso- in a variety of molecular events associated with gene
expression. Studies in yeast have shown that Mi-2 ho-ciation between p300 and the CD4 enhancer. Mi-2 defi-
ciency caused a reduction in the association between mologs exist in at least two separate complexes, one
involved in transcriptional termination (Alen et al., 2002)p300 and the CD4 enhancer, consistent with the reduc-
tion in histone hyperacetylation of this region. p300 is and a second in transcriptional elongation (Krogan et
al., 2002). Studies of Drosophila salivary glands havetherefore likely responsible for the hyperacetylated state
of chromatin at the enhancer, although it is also possible shown that dMi-2 localizes to chromatin puffs, implying
a role in transcriptional activation (Hirose et al., 2002).that other HATs are also recruited to this region.
A direct and specific association between Mi-2 and Recently, vertebrate Mi-2 protein subdomains have
been shown to have both transcriptional repressing andthe proximal CD4 enhancer in CD4-expressing thymo-
cytes was established by ChIP. These studies provide activating properties through their association with dis-
tinct chromatin-modifying enzymes, including Brg-1support for a direct role of Mi-2 in modulating the activ-
ity of the proximal CD4 enhancer, either as part of the (Shimono et al., 2003). The existence of a multiprotein
supercomplex that includes ALL-1, Mi-2, and BrahmaNuRD complex or independently. Mi-2 binding to the
CD4 enhancer may attenuate its activity in CD4-express- as well as HAT, HDAC, and methyl transferase activities
that is bound to the promoter of an active ALL-1-depen-ing thymocytes through the HDAC activity of the NuRD
complex. In the absence of Mi-2, an increase in Mi-2 dent Hox A9 gene was recently reported (Nakamura et
al., 2002). Finally, coimmunoprecipitation studies per-expression (normally present at very low levels) that may
function as a more potent attenuator in the context of formed under this investigation provide strong evidence
that Mi-2 functions in a complex with p300 HAT andthe NuRD complex, may shut down CD4 expression.
However, the direct association between Mi-2 and the HEB in the absence of HDAC.
Our findings reveal interactions in developing T cellsactivators of gene expression, HAT p300 and HEB in
the absence of HDAC, combined with the fact that Mi-2 between Mi-2 and HAT-bearing transcription factors
that are critical for CD4 expression. The CD4 gene isprovides efficient recruitment of these factors to the
CD4 enhancer, precludes this possibility. Rather, these identified as a specific target of Mi-2 during T cell
development, and a function for Mi-2 in the positivedata support a model by which direct binding of
Immunity
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RT-PCRregulation of gene expression in cooperation with HAT
T cells were purified through cell sorting techniques as describedis established. We anticipate that future studies will un-
above. RNA was extracted from specified populations using Trizolcover additional scenarios in which Mi-2 plays a role
(Gibco BRL). Reverse transcription was carried out using random
in the activation of specific genes during development. primers (Georgopoulos et al., 1994). The cDNAs were amplified by
PCR using the primers and conditions shown in Supplemental Table
Experimental Procedures S1 on Immunity’s website. PCR reactions were done in the presence
of 1 
Ci -32P-dCTP, and PCR products were run on 8% acrylamide
Recombination Constructs and Targeting of ES Cells gels and visualized by X-ray films.
The recombination vector described in Figure 1A was constructed
with Mi-2 genomic fragments, a Frt site-flanked neomycin resis- Immunoprecipitations and Western Analysis
tance cassette, and a LoxP recognition site cassette and was tar- Whole-cell lysates and nuclear extracts were prepared from wt and
geted into J1 embryonic stem cells as previous described (Georgo- KO thymocytes and their subsets or thymocytes expressing an Mi-
poulos et al., 1994; Li et al., 1992). DNA was prepared, digested 2flag transgene as previously described (Kim et al., 1999). For immu-
with EcoRI, and analyzed by Southern blotting using a 2 kb EcoRI/ noprecipitation experiments, nuclear extracts were precleared with
BglII digestion fragment DNA probe situated outside the homolo- protein A agarose beads in the presence or absence of 10 
g/mL
gous recombination site (Figure 1A, probe). Mutant ES cells were ethidium bromide to disrupt DNA-protein interactions. Precleared
injected into blastocysts from C57Bl/6 mice. The genotypes of the extracts were immunoprecipitated on protein-A agarose beads with
offspring were determined by EcoRI digestion/Southern blot and by either rabbit IgG, conjugated -p300, conjugated -flag, or -HEB.
polymerase chain reaction (PCR) of tail DNA using the primers and A mock purification of nuclear lysates from wt thymus on anti-flag
conditions shown in the Supplemental Table S1, available on Immu- agarose beads was also performed as a control. Immunoprecipi-
nity’s website. tates on -p300-agarose or -flag-agarose beads were eluted with
100 
g/ml of the N-15 peptide (sc-584 P, Santa Cruz Biotechnology)
Mice or 300 
g/ml of the flag peptide for 1 hr. Eluted proteins were
All mice were bred and housed in specific pathogen-free conditions. separated in SDS-6% polyacrylamide gel electrophoresis and West-
Animals carrying the Lckpr-Cre transgene (Lee et al., 2001) were ern blotted.
identified by PCR genotyping of tail DNA using the primers and
conditions shown in Supplemental Table S1 (available on Immunity’s Chromatin Immunoprecipitation Assays
website). Transgenic mice expressing Flp recombinase were used ChIP and the subsequent PCR analyses were performed as de-
as previously described (Dymecki, 1995). The Mi-2-deficient strain scribed (Harker et al., 2002). The antibodies used are listed in Sup-
was maintained as intercrosses of Mi-2/LoxPF, Lckpr-Cre tg, or Mi- plemental Table S2 on Immunity’s website. All the PCR amplicons
2/, Lckpr-Cre tg X Mi-2LoxPF/LoxPF, and the offspring were geno- for regulatory elements were designed to cover human-mouse con-
typed by PCR and/or Southern blotting of tail DNA. served sequences. The primer sequences used in the multiplex PCR
are available upon request.
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